Health Ministry Warns Against Unapproved Slimming Product After Hospitalization
Translated & summarized from Panet by baba
Israel's Ministry of Health warned the public about the unapproved slimming product "G-Slim" after a young man was hospitalized due to its consumption. Lab tests found the product contains high levels of the banned substance Sibutramine, posing serious health risks.
The story in 5 lines · by baba
- Health Ministry warns against unapproved slimming product G-Slim.
- Product contains banned Sibutramine at dangerous levels.
- Hospitalization reported after consumption of the product.
- Sibutramine poses severe, potentially life-threatening risks.
- Public urged to buy health products only from licensed sources.
Israel's Ministry of Health has issued a public warning against the consumption of "G-Slim," an unapproved slimming product. The warning follows a regulatory enforcement action and a report of a young man being hospitalized after taking the product, experiencing chest pains and rapid heartbeat.
Laboratory tests on G-Slim revealed it contains Sibutramine, an active pharmaceutical ingredient banned in Israel and many other countries due to significant health risks. The product contained 53.8 mg of Sibutramine per capsule, more than three times the amount found in a previously banned similar product.
The Ministry emphasized that Sibutramine can cause severe side effects, including high blood pressure, rapid heartbeat, anxiety, insomnia, heart attacks, strokes, psychological disorders, and can be life-threatening. The exceptionally high concentration in G-Slim exacerbates these dangers.
Health authorities urge the public to avoid counterfeit and unregulated products and to purchase medications, supplements, and health products exclusively from licensed vendors to protect their health.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 7Right 5Haredi 2Arab 1Other 5
